Dmitry S. Belov
Moscow, MOW 119049, Russian Federation
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 17 publications
Combustion Synthesis and Reactive Spark Plasma Sintering of Non-Equiatomic CoAl-Based High Entropy Intermetallics.
Journal: Materials (Basel, Switzerland)
Published: January 09, 2023
Design of gp120 HIV-1 entry inhibitors by scaffold hopping via isosteric replacements.
Journal: European journal of medicinal chemistry
Published: February 08, 2021
Design, synthesis, and antiviral activity of a series of CD4-mimetic small-molecule HIV-1 entry inhibitors.
Journal: Bioorganic & medicinal chemistry
Published: December 03, 2020
Preclinical Optimization of gp120 Entry Antagonists as anti-HIV-1 Agents with Improved Cytotoxicity and ADME Properties through Rational Design, Synthesis, and Antiviral Evaluation.
Journal: Journal of medicinal chemistry
Published: February 08, 2020
Synthesis, Antiviral Activity, and Structure-Activity Relationship of 1,3-Benzodioxolyl Pyrrole-Based Entry Inhibitors Targeting the Phe43 Cavity in HIV-1 gp120.
Journal: ChemMedChem
Published: August 08, 2018
Structure-based lead optimization to improve antiviral potency and ADMET properties of phenyl-1H-pyrrole-carboxamide entry inhibitors targeted to HIV-1 gp120.
Journal: European journal of medicinal chemistry
Published: March 12, 2018
Correction to Synthesis, Antiviral Potency, in Vitro ADMET, and X-ray Structure of Potent CD4 Mimics as Entry Inhibitors That Target the Phe43 Cavity of HIV-1 gp120.
Journal: Journal of medicinal chemistry
Published: May 19, 2017
A Small-Molecule Inhibitor of Prion Replication and Mutant Prion Protein Toxicity.
Journal: ChemMedChem
Published: May 18, 2017
Synthesis, Antiviral Potency, in Vitro ADMET, and X-ray Structure of Potent CD4 Mimics as Entry Inhibitors That Target the Phe43 Cavity of HIV-1 gp120.
Journal: Journal of medicinal chemistry
Published: March 08, 2017
Design, synthesis and evaluation of small molecule CD4-mimics as entry inhibitors possessing broad spectrum anti-HIV-1 activity.
Journal: Bioorganic & medicinal chemistry
Published: August 11, 2016
Fragment-Based Discovery of 5-Arylisatin-Based Inhibitors of Matrix Metalloproteinases 2 and 13.
Journal: ChemMedChem
Published: May 24, 2016
Bicyclic octahydrocyclohepta[b]pyrrol-4(1H)one derivatives as novel selective anti-hepatitis C virus agents.
Journal: European journal of medicinal chemistry
Published: March 04, 2016
Last Updated: 09/26/2026